<DOC>
	<DOCNO>NCT01178177</DOCNO>
	<brief_summary>Invasive pulmonary aspergillosis ( IPA ) opportunistic infection primarily affect recipient solid organ transplant ( SOTs ) patient chemotherapy- induced neutropenia.Although population high risk IPA , differ regard specific defect host defense mechanism increase risk IPA . Chemotherapy- induce neutropenia principal defect affect patient hematologic malignancy , whereas transplant recipient tend dysfunctional T cell phagocytes , result immunosuppressive drug therapy . Thus , pattern IPA-related infection inflammation may differ accord type underlying immune defect . Although clinical radiological feature IPA patient neutropenia extensively study , little known characteristic IPA SOT recipient . The investigator therefore compare IPA- related clinical radiological finding SOT recipient neutropenic patient .</brief_summary>
	<brief_title>Radiologic Features Invasive Pulmonary Aspergillosis</brief_title>
	<detailed_description />
	<mesh_term>Hematologic Diseases</mesh_term>
	<mesh_term>Aspergillosis</mesh_term>
	<mesh_term>Invasive Pulmonary Aspergillosis</mesh_term>
	<mesh_term>Pulmonary Aspergillosis</mesh_term>
	<criteria>IPA case solid organ transplant recipient hematologic disease patient proven probable invasive pulmonary aspergillosis modify EORTC/MSG criterion 16 year old possible case invasive pulmonary aspergillosis</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Invasive pulmonary aspergillosis</keyword>
	<keyword>Solid organ transplantation</keyword>
	<keyword>Hematologic disease</keyword>
</DOC>